subject: GTOPDB:13085

subject_name: adebrelimab

object_name: hormone receptor-positive breast cancer


subject: GTOPDB:13085

object_name: Her2-receptor negative breast cancer

tested_intervention: unsure


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C5785765


subject: UNII:NGB50MQK8N

object_name: paroxysmal atrial fibrillation

tested_intervention: yes


subject: UNII:NGB50MQK8N

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: CHEBI:32150

object_name: digestive system neoplasm


subject: CHEBI:32150

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:32150

object_name: Abnormal enteric nervous system morphology


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:28887

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:28887

object_name: metastatic melanoma


subject: CHEBI:28887

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:4305

subject_name: dacarbazine


subject: UMLS:C2830156

object_name: kidney failure


subject: CHEBI:84500

subject_name: varenicline

object_name: Depressed mood


subject: CHEBI:84500

object_name: Cancer patients and suicide and depression


subject: CHEBI:84500

object_name: Depressed - symptom


subject: CHEBI:84500

object_name: Depression, CTCAE


subject: CHEBI:71013

subject_name: Perampanel

object_name: Partial Seizure


subject: PUBCHEM.COMPOUND:74821141

subject_name: Plazomicin

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:74821141

object_name: Chronic uremia


subject: UMLS:C0699235

subject_name: Nitroderm TTS

object_name: Fetal or neonatal effect of induction of labor


subject: CHEBI:28787

subject_name: Nitroglycerin


subject: UMLS:C5544403

subject_name: Secretome

object_name: liver cirrhosis


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: Advanced cancer


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: endometrial undifferentiated carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: undifferentiated carcinoma of the corpus uteri


subject: PUBCHEM.COMPOUND:2767

object_name: endometrial mixed adenocarcinoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:91872

object_name: endometrial squamous cell carcinoma


subject: CHEBI:91872

object_name: squamous cell carcinoma of the corpus uteri


subject: CHEBI:91872

object_name: endometrial serous adenocarcinoma


subject: CHEBI:91872


subject: CHEBI:91872

object_name: endometrial adenosquamous carcinoma


subject: CHEBI:91872

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:91872

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:91872

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:91872

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:H81695M5OP

subject_name: nattokinase

object_name: Inflammation


subject: UNII:H81695M5OP

object_name: Dyslipidemia


subject: UNII:H81695M5OP

object_name: cardiovascular disorder


subject: UMLS:C0131956


subject: UMLS:C0131956


subject: UMLS:C0131956


subject: UMLS:C0684259

subject_name: Humatrope

object_name: Burn injury


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:7820

subject_name: Oxandrolone


subject: PUBCHEM.COMPOUND:544190

object_name: influenza A


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Refractory acute myeloid leukemia


subject: UNII:WKM56H3TLB

subject_name: Myrcludex B

object_name: viral hepatitis


subject: UNII:WKM56H3TLB

object_name: Viral Hepatitis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5315044

subject_name: ELEBSIRAN


subject: CHEMBL.COMPOUND:CHEMBL5315044


subject: CHEMBL.COMPOUND:CHEMBL5314621

subject_name: TOBEVIBART


subject: CHEMBL.COMPOUND:CHEMBL5314621


subject: UMLS:C5783742

subject_name: Tobevibart


subject: UMLS:C5783742


subject: CHEBI:50692

subject_name: Mifepristone

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:50692

object_name: Prostate cancer recurrent


subject: CHEBI:50692

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:50692

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:50692

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:50692

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: cancer


subject: CHEBI:38290

object_name: neoplasm


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Anal intraepithelial neoplasia


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:36704

subject_name: Imiquimod


subject: MESH:C544151

subject_name: jinfukang


subject: MESH:C544151


subject: CHEBI:47898

subject_name: Epirubicin

object_name: breast adenocarcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Traction detachment of retina due to diabetes mellitus


subject: CHEBI:31348

subject_name: Capecitabine

object_name: colon cancer liver metastasis


subject: CHEBI:27470

subject_name: Folic acid

object_name: arsenic poisoning chronic


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: blood coagulation disease


subject: UMLS:C2825026

object_name: hemorrhagic disease


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:51799

subject_name: Imipenem

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:190509


subject: CHEBI:91950


subject: CHEBI:91950

object_name: ventilator-associated pneumonia


subject: CHEBI:3697

subject_name: Cilastatin


subject: CHEBI:3697


subject: CHEBI:6775

subject_name: Mesalazine

object_name: intestinal disorder


subject: CHEBI:6775

object_name: digestive system disorder


subject: CHEBI:63578

subject_name: Iopromide

object_name: Allergy


subject: CHEBI:63578

object_name: hypersensitivity reaction disease


subject: CHEBI:63578

object_name: Emotional hypersensitivity


subject: UMLS:C0728741

subject_name: Ultravist


subject: UMLS:C0728741


subject: UMLS:C0728741


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: biliary tract cancer


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: vulvar squamous cell carcinoma


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: HIV infection


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: carcinosarcoma of the corpus uteri


subject: PUBCHEM.COMPOUND:131769963

object_name: uterine carcinosarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Uterine Sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Uterine Sarcoma AJCC v7


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:29002

object_name: Skin Wrinkling


subject: CHEBI:28972

subject_name: (R)-Propylene glycol


subject: CHEBI:16997

subject_name: Propylene glycol


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:17345


subject: CHEBI:61695

subject_name: L-prolylglycine


subject: CHEBI:64961


subject: CHEBI:14336

subject_name: glycerol 1-phosphate


subject: CHEBI:64956


subject: CHEBI:64716


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:10607

subject_name: Propyl Gallate


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: acute aortic dissection


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:230430

subject_name: Ulinastatin


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: CHEBI:49668

subject_name: Gefitinib

object_name: malignant mesothelioma


subject: CHEBI:49668

object_name: Mesothelioma malignant recurrent


subject: CHEBI:49668

object_name: malignant epithelioid mesothelioma


subject: CHEBI:49668

object_name: sarcomatoid mesothelioma


subject: CHEBI:4551

subject_name: Digoxin

object_name: Overweight


subject: CHEBI:4551

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4551

object_name: obesity


subject: CHEBI:4551

object_name: Obesity, CTCAE


subject: CHEBI:47426

subject_name: Furosemide

object_name: acute myeloid leukemia


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: TUBERCULOSIS RECURRENT


subject: CHEBI:72296

subject_name: Apixaban

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:72296

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:72296

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: duration of labor (history)


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Tabagism


subject: CHEBI:63631

subject_name: Topiramate

object_name: polyneuropathy


subject: CHEBI:63631

object_name: diabetic neuropathy


subject: UNII:ON7NRB9DD6

object_name: Well adult


subject: UMLS:C4725694


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: Severe Sepsis


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: septic shock


subject: UMLS:C2698151


subject: UMLS:C2698151


subject: UMLS:C1519185

subject_name: Sarna

object_name: Pruritus


subject: UMLS:C2745656

object_name: hepatitis C


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: Childhood Solid Neoplasm


subject: CHEBI:91368

object_name: Adult Solid Neoplasm


subject: CHEBI:91368

object_name: Solid Neoplasm


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033

object_name: lymphoma


subject: PUBCHEM.COMPOUND:961320

subject_name: Tifacogin

object_name: pneumonia


subject: PUBCHEM.COMPOUND:961320

object_name: COVID-19-Associated Pneumonia


subject: UNII:415ZN8YW42

subject_name: TIFACOGIN


subject: UNII:415ZN8YW42


subject: UMLS:C0893651


subject: UMLS:C0893651


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UMLS:C3827082


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165

object_name: Stage IV Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:152165

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: dental phobia


subject: CHEBI:15570

subject_name: D-Alanine

object_name: hereditary fructose intolerance


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: nongerminomatous germ cell tumor


subject: CHEBI:4027

object_name: adult germ cell tumor


subject: CHEBI:4027

object_name: Germ Cell Cancer


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: chronic diarrheal disease


subject: CHEBI:43602

object_name: bile acid malabsorption, primary, 1


subject: CHEBI:43602

object_name: Secondary bile acid malabsorption


subject: CHEBI:80343

subject_name: Mecasermin

object_name: HIV lipodystrophy


subject: UMLS:C0014822

subject_name: Erythropoietin

object_name: hypoplastic left heart syndrome


subject: UMLS:C0014822

object_name: congenital heart disease


subject: UMLS:C0014822

object_name: transposition of the great arteries


subject: CHEBI:6413

subject_name: Letrozole

object_name: leiomyosarcoma


subject: CHEBI:6413

object_name: Childhood Leiomyosarcoma


subject: CHEBI:6413

object_name: Adult Leiomyosarcoma


subject: UNII:GK1LYB375A

subject_name: Tralokinumab

object_name: ulcerative colitis


subject: UNII:GK1LYB375A

object_name: inflammatory bowel disease 1


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: pulmonary sarcoidosis


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:54600498

subject_name: Natrol

object_name: sleep disorder


subject: CHEBI:90942

subject_name: Ixazomib

object_name: leukemia


subject: CHEBI:90942

object_name: childhood leukemia


subject: CHEBI:6801

subject_name: Metformin

object_name: amenorrhea


subject: CHEBI:6801

object_name: Amenorrhea, CTCAE


subject: PUBCHEM.COMPOUND:5460037

subject_name: isomaltotriose

object_name: brain injury


subject: PUBCHEM.COMPOUND:4125253

subject_name: Dextran


subject: CHEBI:52071

subject_name: dextran


subject: CHEBI:34674

subject_name: dextran sulfate


subject: UMLS:C2000818

object_name: Alzheimer disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:89324

object_name: Back pain


subject: CHEBI:89324

object_name: Back Pain, CTCAE 3.0


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:61049

object_name: Autoimmunity


subject: CHEBI:32181

subject_name: Tamibarotene

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:32181

object_name: chronic myelomonocytic leukemia


subject: CHEBI:9570

subject_name: Thiotepa

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:9570

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:9570

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:9570

object_name: Acute leukemia in remission


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:168243

object_name: non-Hodgkin lymphoma


subject: CHEBI:168243

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:168243

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:168243

object_name: Hodgkin Disease


subject: CHEBI:168243

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:168243

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319

object_name: Myelodysplasia


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: CHEBI:33344

subject_name: Niobium

object_name: Overweight


subject: CHEBI:33344

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:33344

object_name: obesity


subject: CHEBI:33344

object_name: Obesity, CTCAE


subject: PR:000011504

subject_name: protein numb


subject: PR:000011504


subject: PR:000011504


subject: PR:000011504


subject: UNII:OWK8BG0FO6

object_name: pancreatic neoplasm


subject: UNII:OWK8BG0FO6

object_name: exocrine pancreatic carcinoma


subject: UNII:OWK8BG0FO6

object_name: malignant pancreatic neoplasm


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140


subject: UMLS:C4725831


subject: UMLS:C4725831


subject: CHEMBL.COMPOUND:CHEMBL4650387


subject: CHEMBL.COMPOUND:CHEMBL4650387


subject: CHEMBL.COMPOUND:CHEMBL4650387


subject: UMLS:C0935953

subject_name: Mobist


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: CHEBI:94534

subject_name: olanzapine

object_name: head and neck squamous cell carcinoma


subject: CHEBI:94534

object_name: Adverse effect of radiation therapy


subject: CHEBI:31938

subject_name: Osalmid

object_name: plasma cell myeloma


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: Geographic atrophy


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UMLS:C0123677

subject_name: NovoLog

object_name: Alzheimer disease


subject: CHEBI:49868

object_name: acute myeloid leukemia


subject: CHEBI:231693

subject_name: Capmatinib

object_name: Metastatic non-small cell lung cancer


subject: UNII:H18SKU3289

subject_name: visilizumab

object_name: acute myeloid leukemia by FAB classification


subject: UNII:H18SKU3289


subject: UNII:H18SKU3289

object_name: Refractory Leukemia


subject: UNII:H18SKU3289

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C1135148

subject_name: Nuvion


subject: UMLS:C1135148


subject: UMLS:C1135148


subject: UMLS:C1135148


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: hyperparathyroidism


subject: CHEBI:60789

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:60789

object_name: Thyroid nodule


subject: CHEBI:60789

object_name: nodule of thyroid by palpation


subject: CHEBI:60789

object_name: thyroid tumor


subject: CHEBI:60789

object_name: nodular goiter


subject: CHEBI:60789

object_name: Graves disease


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: basal cell carcinoma


subject: UMLS:C4053601


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: adult hepatocellular carcinoma


subject: CHEBI:4026

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:4026

object_name: Metastatic hepatocellular carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: liver cancer


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Infection


subject: GTOPDB:4934

object_name: Infection of musculoskeletal system


subject: GTOPDB:4934

object_name: Myelokathexis


subject: GTOPDB:4934

object_name: common wart


subject: GTOPDB:4934

object_name: agammaglobulinemia


subject: GTOPDB:4934

object_name: syndromic agammaglobulinemia


subject: GTOPDB:4934

object_name: leukopenia


subject: GTOPDB:4934

object_name: neutropenia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: diabetes mellitus


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Recurrent ovarian cancer


subject: CHEBI:41423

object_name: fallopian tube carcinoma


subject: CHEBI:41423

object_name: fallopian tube cancer


subject: CHEBI:41423

object_name: peritoneum cancer


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Deficiency of vitamin K2


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:681848

subject_name: Doxapram

object_name: Premature infant


subject: CHEBI:681848

object_name: Apnea


subject: CHEBI:681848

object_name: Apnea, CTCAE


subject: PUBCHEM.COMPOUND:167993668

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:167993668

object_name: neuroblastoma


subject: UMLS:C2351370


subject: UMLS:C2351370


subject: UMLS:C0939731

subject_name: Thyrox

object_name: erythrocyte disorder


subject: UMLS:C0939731

object_name: iron metabolism disease


subject: UMLS:C0939731

object_name: Increased reactive oxygen species production


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Pain score


subject: PUBCHEM.COMPOUND:152165


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:5312

subject_name: gentamicin sulfate

object_name: spinal cord injury


subject: CHEBI:5312

object_name: cauda equina syndrome with neurogenic bladder


subject: CHEBI:5312

object_name: Neurogenic bladder


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: UNII:8X7386QRLV


subject: UNII:8X7386QRLV


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:32682

subject_name: L-argininium

object_name: Abnormality of mitochondrial metabolism


subject: CHEBI:32682

object_name: Ischemia of skeletal muscle


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: UMLS:C4744993

object_name: liver carcinoma


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: High grade glioma


subject: RXCUI:606051

subject_name: ProQuad

object_name: hepatitis A


subject: RXCUI:606051

object_name: rubella


subject: RXCUI:606051

object_name: mumps


subject: RXCUI:606051

object_name: measles


subject: RXCUI:606051

object_name: chickenpox


subject: UMLS:C0005515

subject_name: Biological Factors

object_name: asthma


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride

object_name: Fused vertebrae


subject: CHEBI:9932

object_name: spinal stenosis


subject: CHEBI:9932

object_name: spondylolisthesis


subject: CHEBI:9932

object_name: Congenital spondylolisthesis


subject: CHEBI:9932

object_name: Acquired spondylolisthesis


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: UMLS:C0205992


subject: UMLS:C0205992


subject: UMLS:C0205992


subject: UMLS:C0205992


subject: CHEBI:29548

subject_name: Streptomyces coelicolor calcium-dependent antibiotic CDA4b

object_name: malaria


subject: CHEBI:567361

subject_name: Cladribine


subject: CHEBI:231679

subject_name: ipilimumab

object_name: thyroid tumor


subject: CHEBI:231679

object_name: thyroid cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Klinefelter syndrome


subject: UMLS:C2827069

subject_name: BCG Solution

object_name: superficial urinary bladder carcinoma


subject: UMLS:C2827069

object_name: Stage 0a Bladder Cancer AJCC v8


subject: UMLS:C2827069

object_name: Stage I Bladder Cancer AJCC v8


subject: UMLS:C2827069

object_name: Stage 0is Bladder Cancer AJCC v8


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: eclampsia


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:27958

subject_name: Cocaine

object_name: Iron deficiency


subject: CHEBI:27958

object_name: iron deficiency anemia


subject: UMLS:C1446425

subject_name: Cola antigen


subject: UMLS:C1446425


subject: UMLS:C1623185

subject_name: Cola


subject: UMLS:C1623185


subject: CHEBI:82960

subject_name: Raltegravir

object_name: Childhood Solid Neoplasm


subject: CHEBI:82960

object_name: Adult Solid Neoplasm


subject: CHEBI:82960

object_name: Solid Neoplasm


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: abdominal obesity-metabolic syndrome


subject: HMDB:HMDB0013470

object_name: metabolic syndrome X


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:52603


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: GTOPDB:5019


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PR:000001155


subject: UMLS:C0251514

subject_name: Acthrel

object_name: pituitary gland adenoma


subject: UMLS:C0251514

object_name: Cushing Disease


subject: CHEBI:176724

subject_name: Etiracetam

object_name: migraine


subject: CHEBI:176724

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: UNII:0P1E1UF04I

subject_name: Penehyclidine hydrochloride

object_name: Airway hyperresponsiveness


subject: UNII:0P1E1UF04I

object_name: High risk of


subject: UNII:0P1E1UF04I

object_name: High risk


subject: UNII:0P1E1UF04I

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: UNII:0P1E1UF04I

object_name: High Risk Acute Leukemia


subject: UNII:0P1E1UF04I

object_name: International Prognostic Index High Risk Group


subject: UNII:0P1E1UF04I

object_name: Complication of inhalation therapy


subject: PUBCHEM.COMPOUND:71455937

object_name: cystinosis


subject: CHEMBL.COMPOUND:CHEMBL4297744


subject: UMLS:C4331494

subject_name: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter

object_name: melanoma


subject: UMLS:C4331494

object_name: colorectal carcinoma


subject: UMLS:C4331494

object_name: head and neck squamous cell carcinoma


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: Hemorrhage


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Post-ERCP acute pancreatitis


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: cholangiocarcinoma


subject: PR:000001151

object_name: biliary tract cancer


subject: PR:000001151

object_name: biliary tract neoplasm


subject: PR:000001151

object_name: liver carcinoma


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: peritoneal mesothelioma


subject: CHEBI:194095

object_name: malignant peritoneal mesothelioma


subject: CHEBI:194095

object_name: appendix cancer


subject: CHEBI:194095

object_name: appendix carcinoma


subject: CHEBI:194095

object_name: pseudomyxoma peritonei


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: refractory malignant neoplasm


subject: UNII:D6OMY2L0WA

object_name: Recurrent Carcinoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: CHEBI:17552

subject_name: GDP

object_name: diffuse large B-cell lymphoma


subject: CHEBI:17552


subject: CHEBI:17552


subject: CHEBI:58189


subject: CHEBI:58189


subject: CHEBI:58189


subject: CHEBI:73611

subject_name: Met-Gly


subject: CHEBI:73611

object_name: Liver Fibrosis


subject: CHEBI:73611

object_name: liver disorder


subject: CHEBI:73611

object_name: type 2 diabetes mellitus


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: subarachnoid hemorrhage


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: glycogen storage disease I


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: cancer


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: Primary malignant neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594470

object_name: carcinoma


subject: UMLS:C3896789


subject: UMLS:C3896789


subject: UMLS:C3896789


subject: UMLS:C3896789


subject: UNII:SVT2GC4GOI

subject_name: OPEMALIRSEN

object_name: kidney failure


subject: UMLS:C5908930

subject_name: Opemalirsen


subject: UMLS:C4726880

subject_name: Tolevamer Potassium Sodium

object_name: diarrhea


subject: UMLS:C4726880

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C4726880

object_name: Diarrhea, CTCAE


subject: UMLS:C4726880

object_name: Clostridium difficile colitis


subject: DRUGBANK:DB18418

object_name: spinal muscular atrophy


subject: CHEBI:167636

subject_name: Barasertib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:167636

object_name: acute myeloid leukemia


subject: MESH:C000624274


subject: MESH:C000624274


subject: UMLS:C4076692

subject_name: Autologous fat

object_name: Vocal cord paralysis


subject: CHEBI:8887

subject_name: Rofecoxib

object_name: Stomach cancer


subject: CHEBI:8887

object_name: gastric cancer


subject: UNII:2WTV10SIKH

subject_name: Mitapivat

object_name: non-autoimmune hemolytic anemia


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:2735

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:4910

subject_name: Etomidate

object_name: schizoaffective disorder


subject: CHEBI:4910

object_name: schizophrenia 18


subject: CHEBI:4910

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: PUBCHEM.COMPOUND:9824461


subject: PUBCHEM.COMPOUND:9824461


subject: CHEBI:48923

subject_name: erythromycin

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:48923

object_name: Acute obliterating bronchiolitis


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: UMLS:C2002939

object_name: lung cancer


subject: UMLS:C2002939

object_name: lung neoplasm


subject: UMLS:C2002939

object_name: lung carcinoma


subject: UMLS:C2002939

object_name: non-small cell lung carcinoma


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Ureteral Calculi


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: neoplasm


subject: PUBCHEM.COMPOUND:132203319

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:132203319

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:132203319

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:132203319

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:132203319


subject: UMLS:C5447245

subject_name: RNR Subunits Interaction Inhibitor TAS1553


subject: UMLS:C5447245


subject: UMLS:C5447245


subject: UMLS:C5447245


subject: UMLS:C5447245


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Sepsis


subject: CHEBI:33569

object_name: Sepsis, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Depressed mood


subject: CHEBI:73604

object_name: Cancer patients and suicide and depression


subject: CHEBI:73604

object_name: Depressed - symptom


subject: CHEBI:73604

object_name: Depression, CTCAE


subject: CHEBI:73604


subject: CHEBI:73604

object_name: mental disorder


subject: CHEBI:73604

object_name: psychiatric disorder


subject: CHEBI:73604

object_name: mood disorder


subject: CHEBI:73604

object_name: Atypical behavior


subject: CHEBI:73604

object_name: Suicide


subject: CHEBI:49746

object_name: adrenal cortex carcinoma


subject: CHEBI:49746

object_name: adenoid cystic carcinoma


subject: CHEBI:33382

subject_name: lutetium atom


subject: CHEBI:33382


subject: UNII:BRH40Y9V1Q

subject_name: Lutetium Lu-177


subject: UNII:BRH40Y9V1Q


subject: PUBCHEM.COMPOUND:122706786

subject_name: vipivotide tetraxetan


subject: PUBCHEM.COMPOUND:122706786


subject: UMLS:C5238124


subject: UMLS:C5238124


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage IV adult soft tissue sarcoma


subject: UNII:28X28X9OKV

object_name: Stage IVB adult soft tissue sarcoma


subject: UNII:28X28X9OKV

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:Y38NSX52UM

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: autosomal dominant hypocalcemia


subject: PUBCHEM.COMPOUND:6096882

object_name: Hypocalcemia


subject: PUBCHEM.COMPOUND:6096882

object_name: Serum calcium below normal (finding)


subject: PUBCHEM.COMPOUND:6096882

object_name: Hypocalcemia, CTCAE


subject: PUBCHEM.COMPOUND:6096882

object_name: Hypoparathyroidism following procedure


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:24433

subject_name: group

object_name: Childhood Breast Carcinoma


subject: CHEBI:24433

object_name: breast carcinoma


subject: CHEBI:24433

object_name: breast cancer


subject: CHEBI:73604

object_name: Failed or difficult intubation


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: primary hyperparathyroidism


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Pancreatic adenocarcinoma metastatic


subject: GTOPDB:12347

subject_name: penpulimab


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: neoplasm


subject: CHEBI:38940

subject_name: Sunitinib

object_name: colorectal cancer


subject: CHEBI:38940

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:38940

object_name: Metastasis


subject: CHEBI:38940

object_name: Metastatic Lesion


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: atopic eczema


subject: UMLS:C5226649


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C3641791

object_name: mantle cell lymphoma


subject: UMLS:C3641791


subject: UMLS:C4727207

subject_name: Nidanilimab

object_name: triple-negative breast carcinoma


subject: UMLS:C4727207

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4763757

subject_name: Erfonrilimab


subject: UMLS:C4763757

object_name: colorectal carcinoma


subject: UMLS:C4763757


subject: UMLS:C3494482

subject_name: Mentha piperita extract

object_name: Cognitive changes


subject: UMLS:C1963662

subject_name: Peppermint antigen


subject: UNII:S7RL72610R

subject_name: gossypol acetic acid

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:35450

subject_name: GOSSYPOL ACETIC ACID


subject: PUBCHEM.COMPOUND:22327742

subject_name: Gosspyl acetate


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Non-Erosive Reflux Disease


subject: UMLS:C4330031

subject_name: Gallium Ga 68 P15-041

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C4330031

object_name: prostate carcinoma


subject: UMLS:C4330031

object_name: prostate cancer


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: non-small cell lung carcinoma


subject: UMLS:C1508862

object_name: Resectable non-small cell lung cancer


subject: UMLS:C1508862

object_name: Activating EGFR Gene Mutation


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UNII:74T7185BMM

subject_name: Inebilizumab

object_name: encephalitis


subject: UNII:74T7185BMM

object_name: autoimmune encephalitis


subject: UMLS:C2981806


subject: UMLS:C2981806


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:73151030

object_name: Acute heart failure


subject: UNII:7RPW6SU9SC

object_name: colorectal neoplasm


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Failure to Thrive


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C1961144

object_name: hepatitis C


subject: UMLS:C1961144

object_name: chronic hepatitis C virus infection


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Friedreich ataxia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UMLS:C5783900

subject_name: BCR-ABL Inhibitor ELVN-001

object_name: chronic leukemia


subject: CHEBI:94463

object_name: liver failure


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:8499

subject_name: Propranolol

object_name: Kaposi Sarcoma


subject: CHEBI:68584

subject_name: Ezogabine

object_name: focal epilepsy


subject: CHEBI:4876

subject_name: Etacrynic acid

object_name: bladder tumor


subject: CHEBI:4876

object_name: urinary bladder carcinoma


subject: CHEBI:4876

object_name: urinary bladder cancer


subject: CHEBI:4876

object_name: childhood bladder carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: influenza


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: Dysesthesia


subject: PUBCHEM.COMPOUND:21634109

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:21634109

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:21634109

object_name: Chronic abdominal pain


subject: PUBCHEM.COMPOUND:21634109

object_name: chronic pancreatitis


subject: PUBCHEM.COMPOUND:21634109

object_name: chronic pain syndrome


subject: PUBCHEM.COMPOUND:21634109

object_name: opiate dependence


subject: UNII:OZS4TXB9VO


subject: UMLS:C4329328


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Laryngeal squamous cell carcinoma recurrent


subject: HMDB:HMDB0256702

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: HMDB:HMDB0256702

object_name: tongue cancer


subject: HMDB:HMDB0256702

object_name: tongue carcinoma


subject: HMDB:HMDB0256702

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: HMDB:HMDB0256702

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: HMDB:HMDB0256702

object_name: Laryngeal verrucous carcinoma recurrent


subject: HMDB:HMDB0256702

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: acute diarrhea


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: corneal disease


subject: MESH:C000722357

subject_name: S-268019-b COVID-19 vaccine


subject: CHEBI:73604

object_name: hereditary angioedema


subject: UMLS:C4550039

object_name: demyelinating disease of central nervous system


subject: UMLS:C5206607

subject_name: Anti-CTLA-4 Monoclonal Antibody ADU-1604

object_name: metastatic melanoma


subject: MESH:C521519

subject_name: MVAp53 vaccine

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: MESH:C521519

object_name: stage IV pancreatic cancer


subject: MESH:C521519

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: MESH:C521519

object_name: Stage III Pancreatic Cancer AJCC v8


subject: MESH:C521519

object_name: Pancreatic carcinoma stage III


subject: MESH:C521519

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: MESH:C521519

object_name: Pancreatic carcinoma recurrent


subject: MESH:C521519

object_name: Stage IV Rectal Cancer AJCC v8


subject: MESH:C521519

object_name: Stage IV Rectal Cancer AJCC v7


subject: MESH:C521519

object_name: Rectal cancer stage IV


subject: MESH:C521519

object_name: Stage IV Rectal Cancer AJCC v6


subject: MESH:C521519

object_name: Stage III Rectal Cancer AJCC v6


subject: MESH:C521519

object_name: Stage III Rectal Cancer AJCC v7


subject: MESH:C521519

object_name: Stage III Rectal Cancer AJCC v8


subject: MESH:C521519

object_name: Recurrent Rectal Cancer


subject: MESH:C521519

object_name: Stage IV Colon Cancer AJCC v8


subject: MESH:C521519

object_name: Stage IV Colon Cancer AJCC v6


subject: MESH:C521519

object_name: Stage IV Colon Cancer AJCC v7


subject: MESH:C521519

object_name: Malignant neoplasm of colon stage IV


subject: MESH:C521519

object_name: Malignant neoplasm of stomach stage IV


subject: MESH:C521519

object_name: Colon cancer recurrent


subject: MESH:C521519

object_name: Stage III Colon Cancer AJCC v7


subject: MESH:C521519

object_name: Stage III Colon Cancer AJCC v8


subject: MESH:C521519

object_name: Stage III Colon Cancer


subject: MESH:C521519

object_name: recurrent gastric cancer


subject: MESH:C521519

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: cervical cancer


subject: CHEBI:78887

object_name: cervical carcinoma


subject: UMLS:C3539963

subject_name: Amide local anesthetic combinations

object_name: Neuromuscular inhibition


subject: UMLS:C3539963

object_name: Neuromuscular block, function


subject: UMLS:C3539976

subject_name: Penicillins with extended spectrum combinations


subject: UMLS:C3539976


subject: UMLS:C3540719


subject: UMLS:C3540719


subject: UMLS:C3539181

subject_name: Short-acting sulfonamide combinations


subject: UMLS:C3539181


subject: UMLS:C3540722

subject_name: Beta-lactamase sensitive penicillin combinations


subject: UMLS:C3540722


subject: UMLS:C3539959

subject_name: Long-acting sulfonamide combinations


subject: UMLS:C3539959


subject: UMLS:C3539969

subject_name: Specific immunoglobulin combinations


subject: UMLS:C3539969


subject: UMLS:C3540031

subject_name: gonadotropin combinations


subject: UMLS:C3540031


subject: UMLS:C3540026

subject_name: Hepatitis vaccine combinations


subject: UMLS:C3540026


subject: UMLS:C3539182

subject_name: Salt solution combinations


subject: UMLS:C3539182


subject: UMLS:C3539955

subject_name: lung surfactant combinations


subject: UMLS:C3539955


subject: UMLS:C3539956

subject_name: Magnesium antacid compound combinations


subject: UMLS:C3539956


subject: UMLS:C3539957

subject_name: opium alkaloids and derivative combination cough suppressants


subject: UMLS:C3539957


subject: UMLS:C3539960

subject_name: Other intestinal adsorbent combinations in ATC


subject: UMLS:C3539960


subject: UMLS:C3539961

subject_name: Platelet aggregation inhibitor combinations excl. heparin


subject: UMLS:C3539961


subject: UMLS:C3539962

subject_name: vitamin D and analog combinations


subject: UMLS:C3539962


subject: UMLS:C3539964

subject_name: local opthalmologic anesthetic combinations


subject: UMLS:C3539964


subject: UMLS:C3539965

subject_name: Local hemostatic combinations


subject: UMLS:C3539965


subject: UMLS:C3539966

subject_name: insulins and analogs for injection combinations, long-acting


subject: UMLS:C3539966


subject: UMLS:C3539967

subject_name: Insulins and analogs for injection, intermediate-acting combined with fast-acting- combinations


subject: UMLS:C3539967


subject: UMLS:C3539968

subject_name: Enema combinations


subject: UMLS:C3539968


subject: UMLS:C3539970

subject_name: combination drugs used in erectile dysfunction


subject: UMLS:C3539970


subject: UMLS:C3539971

subject_name: otologic analgesic and anesthetic combinations


subject: UMLS:C3539971


subject: UMLS:C3539972

subject_name: Combination solutions for parenteral nutrition


subject: UMLS:C3539972


subject: UMLS:C3539973

subject_name: Other antifungal combinations for topical use in ATC


subject: UMLS:C3539973


subject: UMLS:C3539974

subject_name: Insulins and analogs for injection, intermediate-acting combinations


subject: UMLS:C3539974


subject: UMLS:C3539975

subject_name: Aluminium antacid compound combinations


subject: UMLS:C3539975


subject: UMLS:C3539977

subject_name: Calcium antacid compound combinations


subject: UMLS:C3539977


subject: UMLS:C3539978

subject_name: expectorant combinations excluding combinations with cough suppressants


subject: UMLS:C3539978


subject: UMLS:C3539979

subject_name: Antiinfective irrigating solution combinations


subject: UMLS:C3539979


subject: UMLS:C3540027

subject_name: Adrenergic and dopaminergic agents combinations


subject: UMLS:C3540027


subject: UMLS:C3540028

subject_name: Other irrigating solution combinations in ATC


subject: UMLS:C3540028


subject: UMLS:C3540030

subject_name: other cough suppressant combinations in ATC


subject: UMLS:C3540030


subject: UMLS:C3540720

subject_name: Caries prophylactic agent combinations


subject: UMLS:C3540720


subject: UMLS:C3540721

subject_name: other nasal preparation combinations in ATC


subject: UMLS:C3540721


subject: UMLS:C3540723

subject_name: Insulins and analogs for injection, fast-acting combinations


subject: UMLS:C3540723


subject: UMLS:C3540724

subject_name: expectorant combinations, excl. combinations with cough suppressants


subject: UMLS:C3540724


subject: UMLS:C3854036

subject_name: Other anti-dementia drug combinations in ATC


subject: UMLS:C3854036


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate

object_name: colon cancer


subject: PUBCHEM.COMPOUND:425400

object_name: Nutrition aspect of cancer


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:22470

subject_name: alpha-tocopherol


subject: CHEBI:22470


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C0291358

subject_name: teicoplanin-polymethylmethacrylate bead

object_name: bacterial infectious disease


subject: UMLS:C1613953

object_name: mild neurocognitive disorder


subject: UMLS:C1613953

object_name: mild cognitive impairment


subject: CHEBI:167656

subject_name: Brivanib alaninate

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:167656

object_name: clear cell renal carcinoma


subject: CHEBI:167656

object_name: renal cell adenocarcinoma


subject: CHEBI:167656

object_name: renal cell carcinoma


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: proteinuria


subject: CHEBI:5778

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:5778

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:5778

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:5778

object_name: end stage renal failure


subject: CHEBI:5778

object_name: Chronic uremia


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Non-small cell lung cancer recurrent


subject: UNII:AF75XOF6W3

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:8892

object_name: Neck Carcinoma


subject: CHEBI:8892

object_name: head and neck neoplasm


subject: CHEBI:8892

object_name: head and neck cancer


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:59905

object_name: septic shock


subject: CHEBI:18243

subject_name: Dopamine


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: anemia


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: UNII:6897GXD6OE

object_name: thrombocytosis


subject: UNII:67SX9H68W2

object_name: non-small cell lung carcinoma


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: mast cell leukemia


subject: UNII:06P3KLK2J8

object_name: Multiple cutaneous leiomyomas


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: leukemia


subject: CHEBI:229212

object_name: childhood leukemia


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: acute coronary syndrome


subject: CHEBI:50634

object_name: brain glioma


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: GTOPDB:12347

subject_name: penpulimab

object_name: Refractory Hepatocellular Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:28445

subject_name: vincristine

object_name: Refractory Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib


subject: PUBCHEM.COMPOUND:71080313

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UMLS:C1327844

object_name: cervical intraepithelial neoplasia


subject: UMLS:C1327844

object_name: dysplasia of cervix


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UMLS:C5237179

subject_name: RAD51 Inhibitor CYT-0851

object_name: Primary malignant neoplasm


subject: UMLS:C5237179

object_name: cancer


subject: UMLS:C5237179

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5237179

object_name: chronic leukemia


subject: UMLS:C5237179

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5237179

object_name: triple-negative breast carcinoma


subject: UMLS:C5237179

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5237179

object_name: small cell lung carcinoma


subject: UMLS:C5237179

object_name: Neck Carcinoma


subject: UMLS:C5237179

object_name: head and neck neoplasm


subject: UMLS:C5237179

object_name: head and neck cancer


subject: UMLS:C5237179

object_name: mantle cell lymphoma


subject: UMLS:C5237179

object_name: plasma cell myeloma


subject: UMLS:C5237179

object_name: pancreatic neoplasm


subject: UMLS:C5237179

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5237179

object_name: malignant pancreatic neoplasm


subject: UMLS:C5237179

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5237179

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5237179

object_name: sarcoma


subject: UMLS:C5237179

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5237179

object_name: soft tissue sarcoma


subject: UMLS:C5237179

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5237179

object_name: non-Hodgkin lymphoma


subject: UMLS:C5237179

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5237179

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5237179

object_name: follicular lymphoma


subject: UMLS:C5237179

object_name: ovarian cancer


subject: UMLS:C5237179

object_name: ovarian neoplasm


subject: UMLS:C5237179

object_name: ovarian carcinoma


subject: UMLS:C5237179

object_name: Childhood Breast Carcinoma


subject: UMLS:C5237179

object_name: breast carcinoma


subject: UMLS:C5237179

object_name: breast cancer


subject: UMLS:C5237179

object_name: diffuse large B-cell lymphoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Primary malignant neoplasm


subject: CHEBI:31348

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:31348

object_name: chronic leukemia


subject: CHEBI:31348

object_name: small cell lung carcinoma


subject: CHEBI:31348

object_name: mantle cell lymphoma


subject: CHEBI:31348

object_name: plasma cell myeloma


subject: CHEBI:31348

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:31348

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:31348

object_name: sarcoma


subject: CHEBI:31348

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:31348

object_name: soft tissue sarcoma


subject: CHEBI:31348

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:31348

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:31348

object_name: follicular lymphoma


subject: CHEBI:31348


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6

object_name: triple-negative breast carcinoma


subject: UNII:4F4X42SYQ6

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: Neck Carcinoma


subject: UNII:4F4X42SYQ6

object_name: head and neck neoplasm


subject: UNII:4F4X42SYQ6

object_name: head and neck cancer


subject: UNII:4F4X42SYQ6

object_name: pancreatic neoplasm


subject: UNII:4F4X42SYQ6

object_name: exocrine pancreatic carcinoma


subject: UNII:4F4X42SYQ6

object_name: malignant pancreatic neoplasm


subject: UNII:4F4X42SYQ6

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:4F4X42SYQ6

object_name: Adult Soft Tissue Sarcoma


subject: UNII:4F4X42SYQ6

object_name: sarcoma


subject: UNII:4F4X42SYQ6

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:4F4X42SYQ6

object_name: soft tissue sarcoma


subject: UNII:4F4X42SYQ6

object_name: ovarian cancer


subject: UNII:4F4X42SYQ6

object_name: ovarian neoplasm


subject: UNII:4F4X42SYQ6

object_name: ovarian carcinoma


subject: UNII:4F4X42SYQ6

object_name: Childhood Breast Carcinoma


subject: UNII:4F4X42SYQ6

object_name: breast carcinoma


subject: UNII:4F4X42SYQ6

object_name: breast cancer


subject: UMLS:C0295415

subject_name: rituximab

object_name: Primary malignant neoplasm


subject: UMLS:C0295415

object_name: triple-negative breast carcinoma


subject: UMLS:C0295415

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0295415

object_name: small cell lung carcinoma


subject: UMLS:C0295415

object_name: Neck Carcinoma


subject: UMLS:C0295415

object_name: head and neck neoplasm


subject: UMLS:C0295415

object_name: head and neck cancer


subject: UMLS:C0295415

object_name: pancreatic neoplasm


subject: UMLS:C0295415

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0295415

object_name: malignant pancreatic neoplasm


subject: UMLS:C0295415

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C0295415

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C0295415

object_name: sarcoma


subject: UMLS:C0295415

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C0295415

object_name: soft tissue sarcoma


subject: UMLS:C0295415

object_name: ovarian cancer


subject: UMLS:C0295415

object_name: ovarian neoplasm


subject: UMLS:C0295415

object_name: ovarian carcinoma


subject: UMLS:C0295415

object_name: Childhood Breast Carcinoma


subject: UMLS:C0295415

object_name: breast carcinoma


subject: UMLS:C0295415

object_name: breast cancer


subject: CHEBI:135515

subject_name: Bendamustine

object_name: chronic leukemia


subject: CHEBI:135515

object_name: head and neck squamous cell carcinoma


subject: CHEBI:135515

object_name: triple-negative breast carcinoma


subject: CHEBI:135515

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:135515

object_name: small cell lung carcinoma


subject: CHEBI:135515

object_name: Neck Carcinoma


subject: CHEBI:135515

object_name: head and neck neoplasm


subject: CHEBI:135515

object_name: head and neck cancer


subject: CHEBI:135515

object_name: pancreatic neoplasm


subject: CHEBI:135515

object_name: exocrine pancreatic carcinoma


subject: CHEBI:135515

object_name: malignant pancreatic neoplasm


subject: CHEBI:135515

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:135515

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:135515

object_name: sarcoma


subject: CHEBI:135515

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:135515

object_name: soft tissue sarcoma


subject: CHEBI:135515

object_name: ovarian cancer


subject: CHEBI:135515

object_name: ovarian neoplasm


subject: CHEBI:135515

object_name: ovarian carcinoma


subject: UMLS:C0019593

subject_name: Histamine H2 Antagonists

object_name: head and neck squamous cell carcinoma


subject: UMLS:C0019593

object_name: pancreatic adenocarcinoma


subject: UMLS:C0019593

object_name: malignant soft tissue neoplasm


subject: UMLS:C0019593


subject: UMLS:C0019593

object_name: solitary fibrous tumor


subject: UMLS:C0019593

object_name: dedifferentiated liposarcoma


subject: UMLS:C3536872

subject_name: Histamine-2 Receptor Antagonist [EPC]


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UMLS:C3536872


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:188074

object_name: type 1 diabetes mellitus


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:357241

subject_name: glycinexylidide

object_name: pancreatic neoplasm


subject: CHEBI:357241

object_name: exocrine pancreatic carcinoma


subject: CHEBI:357241

object_name: malignant pancreatic neoplasm


subject: PR:000013661

subject_name: Ras-related C3 botulinum toxin substrate 2


subject: PR:000013661


subject: PR:000013661


subject: PR:000035208

subject_name: elongation factor P--(R)-beta-lysine ligase


subject: PR:000035208


subject: PR:000035208


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:49200

object_name: Upper Gastrointestinal Hemorrhage, CTCAE


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: UMLS:C3540020

subject_name: Proton pump inhibitors for peptic ulcer and GORD


subject: UMLS:C3540020


subject: DRUGBANK:DB18439

object_name: skin melanoma


subject: DRUGBANK:DB18439

object_name: metastatic melanoma


subject: DRUGBANK:DB18439

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: DRUGBANK:DB18439

object_name: melanoma


subject: MESH:D019444

subject_name: Vaccines, DNA


subject: MESH:D019444


subject: MESH:D019444


subject: MESH:D019444


subject: UMLS:C5392750

object_name: chronic obstructive pulmonary disease


subject: CHEBI:142077

subject_name: Abediterol


subject: CHEBI:7459

subject_name: Naloxone

object_name: constipation, impaction, and bowel obstruction


subject: CHEBI:7459

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: Primary malignant neoplasm


subject: UMLS:C3640820

subject_name: Saccharomyces boulardii Probiotic Supplement

object_name: enterocolitis


subject: UMLS:C3640820

object_name: Enterocolitis, CTCAE


subject: UMLS:C3640820

object_name: Hirschsprung disease


subject: UMLS:C3640820

object_name: Hirschsprung disease, susceptibility to, 1


subject: CHEBI:84123

subject_name: advanced glycation end-product

object_name: type 2 diabetes mellitus


subject: CHEBI:84123

object_name: coronary artery disorder


subject: CHEBI:84123

object_name: coronary atherosclerosis


subject: CHEBI:84123

object_name: coronary microvascular disorder


subject: PR:000013884

subject_name: N-acylglucosamine 2-epimerase


subject: PR:000013884


subject: PR:000013884


subject: PR:000013884


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Kaposi Sarcoma


subject: CHEBI:52717

object_name: Recurrent Kaposi Sarcoma


subject: CHEBI:52717

object_name: HIV infection


subject: UMLS:C5667012

subject_name: SHP2 Inhibitor HBI-2376

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667012

object_name: Adult Solid Neoplasm


subject: UMLS:C5667012

object_name: Solid Neoplasm


subject: UMLS:C5667012

object_name: non-small cell lung carcinoma


subject: UMLS:C5667012

object_name: pancreatic neoplasm


subject: UMLS:C5667012

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5667012

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667012

object_name: colon cancer


subject: UMLS:C5667012

object_name: colorectal cancer


subject: UMLS:C5667012

object_name: colorectal carcinoma


subject: UMLS:C5667012

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5667012

object_name: cancer


subject: UMLS:C5667012

object_name: neoplasm


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: liver carcinoma


subject: UNII:29DKI2H2NY

subject_name: Tinostamustine

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:29DKI2H2NY

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:29DKI2H2NY

object_name: primary cutaneous T-cell lymphoma


subject: UNII:29DKI2H2NY

object_name: Hodgkin Disease


subject: UNII:29DKI2H2NY

object_name: plasma cell myeloma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Erdheim-Chester disease


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: invasive breast carcinoma


subject: UNII:234248D0HH

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:234248D0HH

object_name: Multifocal breast carcinoma


subject: UNII:234248D0HH

object_name: synchronous bilateral breast carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: congenital pulmonary sequestration


subject: CHEBI:60802

object_name: congenital pulmonary airway malformation


subject: CHEBI:60802

object_name: bronchogenic cyst


subject: CHEBI:8892

object_name: Cushing Disease


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: female reproductive organ cancer


subject: CHEBI:28689

subject_name: Prasterone


subject: PUBCHEM.COMPOUND:11531537

subject_name: Eliglustat

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:11531537

object_name: neuroblastoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: cocaine use disorder


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Corneal epithelial wound


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:27563

subject_name: arsenic atom


subject: CHEBI:233101

subject_name: Ala-Ser


subject: CHEBI:47217

subject_name: arsane


subject: CHEBI:63918

subject_name: Artesunate


subject: CHEBI:35828


subject: PR:000022165

subject_name: putative sulfatase AslA


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Stage I Prostate Cancer AJCC v6


subject: UMLS:C1882421

object_name: Prostate cancer stage I


subject: UMLS:C1882421

object_name: Stage I Prostate Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage I Prostate Cancer AJCC v7


subject: UMLS:C1882421

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UMLS:C1882421

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C5557203

subject_name: Vevoctadekin

object_name: Childhood Solid Neoplasm


subject: UMLS:C5557203

object_name: Adult Solid Neoplasm


subject: UMLS:C5557203

object_name: Solid Neoplasm


subject: UMLS:C5557203

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5557203

object_name: triple-negative breast carcinoma


subject: UMLS:C5557203

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5557203

object_name: non-small cell lung carcinoma


subject: UMLS:C5557203

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5557203

object_name: clear cell renal carcinoma


subject: UMLS:C5557203

object_name: renal cell adenocarcinoma


subject: UMLS:C5557203

object_name: renal cell carcinoma


subject: UMLS:C5557203

object_name: cancer


subject: UMLS:C5557203

object_name: neoplasm


subject: UMLS:C5557203

object_name: carcinoma


subject: UMLS:C5557203

object_name: melanoma


subject: UMLS:C5557203

object_name: MSI-high


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:60799

subject_name: Esketamine

object_name: Opioid use, unspecified


subject: UMLS:C5706553

subject_name: Anti-HER2 Antibody-drug Conjugate BL-M07D1

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: fibromyalgia


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:145374

subject_name: Enasidenib

object_name: T-Cell Lymphoma


subject: CHEBI:145374

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:229764

subject_name: Selinexor

object_name: endometrial cancer


subject: CHEBI:229764

object_name: uterine corpus cancer


subject: CHEBI:229764

object_name: endometrial carcinoma


subject: GTOPDB:9847

subject_name: fontolizumab

object_name: rheumatoid arthritis


subject: UNII:6J92H2439Z


subject: UMLS:C1682646


subject: CHEBI:8499

subject_name: Propranolol

object_name: postpartum hemorrhage


subject: CHEBI:8499

object_name: Post-partum hemorrhage


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: marginal zone lymphoma


subject: CHEBI:28887

object_name: MALT lymphoma


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:7726

subject_name: octreotide

object_name: anemia


subject: CHEBI:7726

object_name: Anemia, CTCAE


subject: CHEBI:7726

object_name: angiodysplasia


subject: CHEBI:7726

object_name: Gastrointestinal hemorrhage


subject: CHEBI:7726

object_name: vascular malformation


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: Tractional retinal detachment


subject: UMLS:C2352201

subject_name: Conbercept


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: Cachexia


subject: CHEBI:55352

object_name: Advanced cancer


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:2904


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: renal cell carcinoma


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: metastatic melanoma


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: inappropriate ADH syndrome


subject: CHEBI:6456

subject_name: Lidocaine

object_name: periodontal disorder


subject: CHEBI:6456

object_name: periodontitis


subject: CHEBI:6456

object_name: Periodontal Disease, CTCAE


subject: CHEBI:8404

subject_name: Prilocaine


subject: CHEBI:8404


subject: CHEBI:8404


subject: CHEBI:4575

subject_name: Dihydromorphine

object_name: Insomnia due to anxiety and fear


subject: CHEBI:182794

subject_name: (+/-)-Dihydromethysticin


subject: CHEBI:71175


subject: UMLS:C3489521

subject_name: dihydromethysticin


subject: CHEBI:16646

subject_name: carbohydrate

object_name: age


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Disorder of cervical spine


subject: CHEBI:15940

subject_name: Niacin

object_name: hyperphosphatemia


subject: CHEBI:15940

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEBI:15940

object_name: Hyperphosphatemia, CTCAE


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: enteropathy-associated T-cell lymphoma


subject: PUBCHEM.COMPOUND:2767

object_name: ALK-negative anaplastic large cell lymphoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:41423

subject_name: Celecoxib

object_name: squamous cell carcinoma


subject: CHEBI:3175

subject_name: Brimonidine

object_name: Has drooping eyelids


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: cardiac arrest


subject: CHEBI:46245

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:46245

object_name: cardiac conduction defect


subject: CHEBI:46245

object_name: sudden cardiac arrest


subject: CHEBI:46245

object_name: Aborted sudden cardiac death


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: colorectal neoplasm


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:15936

subject_name: Xylose


subject: CHEBI:65327

subject_name: D-xylose


subject: DRUGBANK:DB17891

subject_name: Fazirsiran

object_name: Hepatic impairment


subject: CHEBI:2611

subject_name: Alprazolam

object_name: generalized anxiety disorder


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Clinical Stage I Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage II Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IIC Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IIA Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IIB Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IA Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IB Cutaneous Melanoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: metastatic melanoma


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UMLS:C4287651


subject: UNII:3YEA04NV6H

subject_name: Silatecan

object_name: Myelodysplasia


subject: UNII:3YEA04NV6H

object_name: Adult Myelodysplastic Syndrome


subject: UNII:3YEA04NV6H

object_name: childhood myelodysplastic syndrome


subject: UNII:3YEA04NV6H

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0961890


subject: UMLS:C0961890


subject: UMLS:C0961890


subject: UMLS:C0961890


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Noonan syndrome


subject: UNII:NQX9KB6PCL

object_name: Noonan syndrome 1


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Glucose metabolism disorders (incl diabetes mellitus)


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:6801

subject_name: Metformin

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: psychosis


subject: PUBCHEM.COMPOUND:3249

object_name: Nonorganic psychosis


subject: PUBCHEM.COMPOUND:3249

object_name: Psychosis, CTCAE


subject: PUBCHEM.COMPOUND:3249

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:3249

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:3249

object_name: schizophrenia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:4672

object_name: Rectal cancer stage IV


subject: CHEBI:4672

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:4672

object_name: Recurrent Rectal Cancer


subject: CHEBI:4672

object_name: Colon cancer recurrent


subject: CHEBI:4672

object_name: Small cell lung cancer extensive stage


subject: CHEBI:4672

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:4672

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:4672

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1514791

subject_name: Recombinant Vaccinia-CEA


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791

object_name: Small cell lung cancer recurrent


subject: UMLS:C1514791

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C1514791

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UMLS:C1514791


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:8772

subject_name: Raloxifene

object_name: postmenopausal osteoporosis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Duchenne muscular dystrophy


subject: CHEBI:90942

subject_name: Ixazomib

object_name: AL amyloidosis


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UNII:KXG2PJ551I

object_name: human papillomavirus-related penile squamous cell carcinoma


subject: UNII:KXG2PJ551I

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: UNII:KXG2PJ551I

object_name: HPV-associated cervical carcinoma


subject: UNII:KXG2PJ551I

object_name: HPV-related carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C4727823

subject_name: HPV16 E6/E7-encoding MVA Vaccine TG4001


subject: UMLS:C4727823


subject: UMLS:C4727823


subject: UMLS:C4727823


subject: UMLS:C4727823


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ovarian sex cord-stromal tumor


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Childhood Breast Carcinoma


subject: CHEBI:68534

object_name: breast carcinoma


subject: CHEBI:68534

object_name: breast cancer


subject: CHEBI:84363

object_name: postprandial hypotension


subject: CHEBI:2376

subject_name: acarbose


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: severe combined immunodeficiency


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:82339

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:82339

object_name: congenital amegakaryocytic thrombocytopenia 1


subject: CHEBI:82339

object_name: refractory hairy cell leukemia


subject: CHEBI:82339

object_name: severe congenital neutropenia


subject: CHEBI:82339

object_name: Diamond-Blackfan anemia


subject: CHEBI:82339

object_name: Aase syndrome


subject: CHEBI:82339

object_name: Shwachman-Diamond syndrome


subject: CHEBI:82339

object_name: Shwachman-Diamond syndrome 1


subject: CHEBI:82339

object_name: Wiskott-Aldrich syndrome


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:93775

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:93775

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:93775

object_name: aplastic anemia


subject: CHEBI:93775

object_name: idiopathic aplastic anemia


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:50681

object_name: severe combined immunodeficiency


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:61057

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:61057

object_name: severe congenital neutropenia


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:131769963

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:131769963

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:131769963

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Basophilic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Acute Eosinophilic Leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Erythroleukemia


subject: UNII:5XYK65KIGD

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:5XYK65KIGD

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:5XYK65KIGD

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:5XYK65KIGD

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:5XYK65KIGD

object_name: recurrent adult acute myeloid leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: UNII:5XYK65KIGD

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UNII:5XYK65KIGD

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UNII:5XYK65KIGD

object_name: Adult Acute Monoblastic Leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Pure Erythroid Leukemia


subject: UNII:5XYK65KIGD

object_name: acute megakaryoblastic leukemia in adult


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Acute Myelomonocytic Leukemia


subject: UNII:5XYK65KIGD

object_name: adult acute monocytic leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Acute Basophilic Leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Acute Eosinophilic Leukemia


subject: UNII:5XYK65KIGD

object_name: Adult Erythroleukemia


subject: CHEBI:50924

subject_name: Sorafenib

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:50924

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:50924

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:50924

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:50924

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:50924

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:50924

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:50924

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:50924

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:50924

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:50924

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:50924

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:50924

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:50924

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:50924

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:50924

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:50924

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:50924

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:50924

object_name: adult acute monocytic leukemia


subject: CHEBI:50924

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:50924

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:50924

object_name: Adult Erythroleukemia


subject: UMLS:C0876183

subject_name: Thyrogen

object_name: Graves disease


subject: CHEBI:8347

subject_name: Povidone-iodine

object_name: Candida auris infection


subject: CHEBI:8347

object_name: Asymptomatic Colonization


subject: CHEBI:90936

subject_name: Alectinib

object_name: Advanced Sarcoma


subject: CHEBI:90936

object_name: Advanced Breast Carcinoma


subject: CHEBI:90936

object_name: Advanced Prostate Carcinoma


subject: CHEBI:90936

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:90936

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:90936

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:90936

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:90936

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:90936

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90936

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:90936

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:90936

object_name: Prostate cancer recurrent


subject: CHEBI:90936

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:90936

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:90936

object_name: Recurrent ovarian cancer


subject: CHEBI:90936

object_name: Breast cancer recurrent


subject: CHEBI:90936

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:231324

subject_name: alpelisib

object_name: Advanced Sarcoma


subject: CHEBI:231324

object_name: Advanced Breast Carcinoma


subject: CHEBI:231324

object_name: Advanced Prostate Carcinoma


subject: CHEBI:231324

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:231324

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:231324

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:231324

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:231324

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:2704

subject_name: Anastrozole


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:2704

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:2704

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:2704

object_name: Prostate cancer recurrent


subject: CHEBI:2704


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:51038893

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:195558

subject_name: Entrectinib

object_name: Advanced Sarcoma


subject: CHEBI:195558

object_name: Advanced Breast Carcinoma


subject: CHEBI:195558

object_name: Advanced Prostate Carcinoma


subject: CHEBI:195558

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:195558

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:195558

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:195558

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:195558

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602